Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Alternative splicing of the human glucocorticoid receptor (hGR) pre-mRNA generates two highly homologous isoforms, termed hGR alpha and hGR beta. hGR alpha is a ligand-activated transcription factor which, in the hormone-bound state, modulates the expression of glucocorticoid-responsive genes by binding to specific glucocorticoid response element (GRE) DNA sequences. In contrast, hGR beta does not bind glucocorticoids and is transcriptionally inactive. We demonstrate here that hGR beta is able to inhibit the effects of hormone-activated hGR alpha on a glucocorticoid-responsive reporter gene in a concentration-dependent manner. [3H]-Dexamethasone binding studies indicate that hGR beta does not alter the affinity of hGR alpha for its hormonal ligand. The presence of hGR beta in nuclear extracts and its ability to bind to a radiolabeled GRE oligonucleotide suggest that its inhibitory effect may be due to competition for GRE target sites. Reverse transcription-PCR analysis shows expression of hGR beta mRNA in multiple human tissues. These results indicate that hGR beta may be a physiologically and pathophysiologically relevant endogenous inhibitor of glucocorticoid action, which may participate in defining the sensitivity of target tissues to glucocorticoids. They also underline the importance of distinguishing between the two receptor isoforms in all future studies of hGR function and the need to revisit old data.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These GR variants are derived from a single gene by alternative splicing and alternative translation initiation mechanisms.”
From Corticosteroids (2016) · cites this paper as [43]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Exon 2 forms the N-terminal domain of GR, exon 3–4 constitute the central DBD, while exons 5–9 code for the hinge and ligand-binding domain.”
From Corticosteroids (2016) · cites this paper as [43]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Alternative splicing at exon 9 of primary GR transcript generates two highly homologous mRNA transcripts that results in the production of two GR isoforms termed GRα and GRβ (Fig.3A)43, 44.”
From Corticosteroids (2016) · cites this paper as [43]
In the citing paper
“The conventional belief that glucocorticoids act through a single GR protein has changed dramatically with the discovery of a diverse collection of receptor isoforms.”
From Corticosteroids (2016) · cites this paper as [43]
In the citing paper
“The GR protein is encoded by the Nr3c1 gene and consists of 9 exons; exon 1 forms the 5’-untranslated region, while exon 2–9 code for the GR protein.”
From Corticosteroids (2016) · cites this paper as [43]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439 · cited 1×
“receptor complex with other DNA elements and/or nuclear proteins then modulate the rate at which these genes are transcribed (6-8).”
BackgroundLipofection: a highly efficient, lipid-mediated DNA-transfection procedure.
Felgner, P. L., Gadek, T. R., Holm, M., Roman, R., Chan, H. W., Wenz, M., Northrop, J. P., Ringold, G. M., & Danielsen, M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.21.7413 · Cited by 4,978
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.15.6419 · Cited by 4,179 · cited 1×
“48 h after transfection, cells were washed twice with PBS, and nuclear extracts were prepared essentially as described elsewhere (18).”
MethodThe Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Self-citationSTEROID RECEPTOR REGULATED TRANSCRIPTION OF SPECIFIC GENES AND GENE NETWORKS
Yamamoto, K. R. (1985) · Annual Review of Genetics · doi:10.1146/annurev.ge.19.120185.001233 · Cited by 1,872
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869 · cited 3×
“This difference renders hGRJ3 unable to bind glucocorticoid hormones and to be transcriptionally active (9, 11-14).”
BackgroundJonat, C., Rahmsdorf, H. J., Park, K.-K., Cato, A. C. B., Gebel, S., Ponta, H., & Herrlich, P. (1990) · Cell · doi:10.1016/0092-8674(90)90395-u · Cited by 1,566 · cited 1×
“Formation of non-GRE/DNA-binding complexes with the glucocorticoid receptor is believed to be the predominant mechanism by which previously described inhibitors of glucocorticoid action, such as c-jun (23-25), calreticulin (26, 27), and”
BackgroundYang-Yen, H.-F., Chambard, J.-C., Sun, Y.-L., Smeal, T., Schmidt, T. J., Drouin, J., & Karin, M. (1990) · Cell · doi:10.1016/0092-8674(90)90396-v · Cited by 1,553
Functional inactivation of genes by dominant negative mutations
Herskowitz, I. (1987) · Nature · doi:10.1038/329219a0 · Cited by 1,160 · cited 1×
“its transcriptionally active counterpart, and, therefore, fits the definition of a dominant negative inhibitor of hGRa (20).”
Background
Cited by
Items 301–400 of 640
Recent advances in the molecular mechanisms causing primary generalized glucocorticoid resistance
Nicolaides, N. C., Lamprokostopoulou, A., Sertedaki, A., & Charmandari, E. (2016) · HORMONES · doi:10.14310/horm.2002.1660 · Cited by 36
Gašić, V., Zukić, B., Stanković, B., Janić, D., Dokmanović, L., Lazić, J., Krstovski, N., Dolžan, V., Jazbec, J., Pavlović, S., et al. (2018) · Radiology and Oncology · doi:10.2478/raon-2018-0034 · Cited by 36
Montaño, L. M., Flores‐Soto, E., Sommer, B., Solís‐Chagoyán, H., & Perusquía, M. (2019) · Steroids · doi:10.1016/j.steroids.2019.108509 · Cited by 34
Syed, A. A., Halpin, C. G., Irving, J. A. E., Unwin, N. C., White, M., Bhopal, R. S., Redfern, C. P. F., & Weaver, J. U. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03175.x · Cited by 34
Zou, Y., Xu, J., Wang, F., Liu, S., Tao, J., Cai, J., Li, L., Xiao, H., Chen, P.-L., Tian, G., et al. (2013) · Autoimmunity · doi:10.3109/08916934.2013.830714 · Cited by 33
“Although the exact physiological function of GRb is still unknown, transfection studies have shown that GRb is the dominant inhibitor of GRa activity [18,21].”
BackgroundThe Glucocorticoid Receptor Is Overexpressed in Malignant Adrenocortical Tumors
Tacon, L. J., Soon, P. S. H., Gill, A. J., Chou, A. S. Y., Clarkson, A., Botling, J., Stalberg, P. L. H., Skogseid, B. M., Robinson, B. G., Sidhu, S. B., et al. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0546 · Cited by 35
Buoso, E., Galasso, M., Ronfani, M., Serafini, M. M., Lanni, C., Corsini, E., & Racchi, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.03.019 · Cited by 36
Perkins, M., Toit, R. L.-D., & Africander, D. (2017) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2017.07.022 · Cited by 46
Importance of glucocorticoid receptors in upper and lower airways
Pujols, L., Mullol, J., & Picado, C. (2009) · Frontiers in bioscience · doi:10.2741/3646 · Cited by 34
“In certain cell types, when over-expressed with respect to GR alpha, GR beta inhibits both the transactivation activity of GR alpha (13, 41-43) and the capacity of GR alpha to repress AP-1- and NF-kappa B-dependent promoters (41).”
BackgroundMifepristone Inhibits GRβ Coupled Prostate Cancer Cell Proliferation
Ligr, M., Li, Y., Logan, S. K., Taneja, S. S., Melamed, J., Lepor, H., Garabedian, M. J., & Lee, P. (2012) · The Journal of Urology · doi:10.1016/j.juro.2012.04.102 · Cited by 34
Steroid Receptors in the Uterus: Implications in Endometriosis
Moutsatsou, P., & Sekeris, C. E. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.024 · Cited by 35
Investigating the anti-mineralocorticoid properties of synthetic progestins used in hormone therapy
Africander, D., Toit, R. L.-D., & Hapgood, J. P. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.02.086 · Cited by 38
Xie, Y., Meng, Y., Li, H. ‐., Hong, Y., Sun, L., Zhu, X., Yue, Y.-X., Gao, X., Wang, S., Li, Y., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.13040 · Cited by 34
“GRb acts as a major negative inhibitor of GRa activity by competitively binding to GR-interacting proteins [23].”
BackgroundGlucocorticoid receptor gene polymorphisms in ACTH‐secreting pituitary tumours
Antonini, S. R. R., Latronico, A. C., Elias, L. L. K., Cukiert, A., Machado, H. R., Liberman, B., Mendonca, B. B., Moreira, A. C., & de Castro, M. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01639.x · Cited by 35
Solakidi, S., Psarra, A. G., & Sekeris, C. E. (2007) · PubMed · Cited by 31
New insights into steroid resistant asthma
Leung, D. Y. M., & Szefler, S. J. (1998) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.1998.tb00293.x · Cited by 31
Prednicarbate Versus Conventional Topical Glucocorticoids: Pharmacodynamic Characterization In Vitro
Lange, K., Gysler, A., Bäder, M., Kleuser, B., Körting, H. C., & Schäfer-Korting, M. (1997) · Pharmaceutical Research · doi:10.1023/a:1012183914011 · Cited by 31
Bray, P. J., Du, B., Mejia, V. M., Hao, S. C., Deutsch, E., Fu, C., Wilson, R. C., Hanauske-Abel, H. M., & McCaffrey, T. A. (1999) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.19.5.1180 · Cited by 36
Bellemare, J., Rouleau, M., Harvey, M., Têtu, B., & Guillemette, C. (2009) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.64 · Cited by 30
Gola, H., Engler, A., Morath, J., Adenauer, H., Elbert, T., Kolassa, I.-T., & Engler, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086333 · Cited by 30
“Since this region contains important parts of the ligand binding domain, GRb is unable to bind natural and synthetic GCs such as cortisol and dexamethasone, respectively [11,12].”
BackgroundThe impact of genetic factors on response to glucocorticoids therapy in IBD
Gabryel, M., Skrzypczak-Zielińska, M., Kucharski, M., Słomski, R., & Dobrowolska, A. (2016) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1132336 · Cited by 35
“[34] It can be estimated that the level of GR beta must have been at least 5–10 times higher to have a significant influence on the sensitivity of GCs treatment.[30] It was proven that GR beta expression is induced by inflammatory mediators [38] and is higher in patients with exacerbation of UC – in whom the inflammat…”
BackgroundBury, N. R. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.06.030 · Cited by 33
“It does, however, form 85 heterodimers with GRα to act as a dominant-negative inhibitor of GRα gene expression 86 (Bamberger et al 1995), and has also been shown to directly stimulate or repress a number 87 of genes not regulated by GRα (Kino et al 2009, Lewis-Tuffin et al 2007).”
BackgroundMineralocorticoid Action in the Aldosterone-Sensitive Distal Nephron
Verrey, F., Hümmler, E., Schild, L., & Rossier, B. C. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50035-8 · Cited by 34
Generalized and tissue specific glucocorticoid resistance
Martins, C. S., & de Castro, M. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111277 · Cited by 32
Expression of glucocorticoid receptor mRNAs in glucocorticoid-resistant nasal polyps
Choi, B.-R., Kwon, J., Gong, S.-J., Kwon, M.-S., Cho, J.-H., Kim, J. H., Oh, S., Roh, H.-J., & Kim, D. (2006) · Experimental & Molecular Medicine · doi:10.1038/emm.2006.55 · Cited by 30
“This hypothesis on the inhibitory effect of hGRβ in hGRα-mediated transcription has been tested in vitro with tissues obtained from corticoresistant asthmatics (Bamberger et al., 1995; Oakley et al., 1996).”
Effectiveness of intratympanic dexamethasone for refractory sudden sensorineural hearing loss
Erdur, Ö., Kayhan, F. T., & Cırık, A. A. (2013) · European Archives of Oto-Rhino-Laryngology · doi:10.1007/s00405-013-2594-x · Cited by 29
“According to one theory, variations in the cochlear distribution of glucocorticoid receptor subtypes may account for this [20].”
BackgroundGlucocorticoid Receptor in Human Respiratory Epithelial Cells
Pujols, L., Mullol, J., & Picado, C. (2009) · NeuroImmunoModulation · doi:10.1159/000216187 · Cited by 31
Role of Hormones in the Regulation of RACK1 Expression as a Signaling Checkpoint in Immunosenescence
Racchi, M., Buoso, E., Ronfani, M., Serafini, M. M., Galasso, M., Lanni, C., & Corsini, E. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18071453 · Cited by 31
“Indeed, there is evidence that GRβ acts as a dominant negative of GRα [50,51].”
BackgroundMolecular mechanisms contributing to glucocorticoid resistance in lymphoid malignancies
Scheijen, B. (2019) · Cancer Drug Resistance · doi:10.20517/cdr.2019.29 · Cited by 41
“This unique GRb sequence abrogates ligand binding, and yields a constitutive nuclear isoform that has been reported to act as a dominant-negative inhibitor of GRa on genes both positively and negatively regulated by GCs([62,63]), although this has been disputed by others([64-66]).”
BackgroundCalcium Checks cyclic AMP - Corticosteroid Feedback in Adenohypophysial Corticotrophs
Antoni, F. A. (1996) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1996.tb00703.x · Cited by 31
Corticosteroid Receptors, 11β-Hydroxysteroid Dehydrogenase, and the Heart
Sheppard, K. E. (2003) · Vitamins and hormones · doi:10.1016/s0083-6729(03)01003-3 · Cited by 30
Yi-ming, M., Takayanagi, R., Imasaki, K., Ohe, K., Ikuyama, S., Yanase, T., & Nawata, H. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00520.x · Cited by 29
Funato, H., Kobayashi, A., & Watanabe, Y. (2006) · Brain Research · doi:10.1016/j.brainres.2006.08.029 · Cited by 28
The Biologist’s Guide to the Glucocorticoid Receptor’s Structure
Deploey, N., Moortel, L. V., Rogatsky, I., Peelman, F., & Bosscher, K. D. (2023) · Cells · doi:10.3390/cells12121636 · Cited by 32
“This receptor variant acts as a dominant-negative inhibitor of GRα but has also been shown to have intrinsic, GRα-independent transcriptional activities [49,50].”
BackgroundHapgood, J. P., & Tomasicchio, M. (2010) · Archives of Virology · doi:10.1007/s00705-010-0678-0 · Cited by 32
“This results in the loosening of chromatin structure by histone acetylation through the intrinsic histone acetyltransferase (HAT) activity of co-activators, which facilitates the binding of transcription machinery components to DNA [33, 34].”
Backgroundvan Winsen, L. M. L., Veen, T. H.-V., van Rossum, E. F. C., Polman, C. H., van den Berg, T. K., Koper, J. W., & Uitdehaag, B. M. J. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.06.010 · Cited by 29
“The glucocorticoid receptor (GR) consists of a hormonebinding domain, a DNA-binding domain and the aminoterminal region (Bamberger et al., 1995), and plays a role in determining GC sensitivity.”
BackgroundFingert, J. H., Alward, W. L. M., Wang, K., Yorio, T., & Clark, A. F. (2010) · PubMed Central · Cited by 38
16α-Hydroxyprogesterone: Origin, biosynthesis and receptor interaction
Storbeck, K., Swart, P., Africander, D., Conradie, R., Toit, R. L.-D., & Swart, A. C. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.016 · Cited by 32
Martínez, T. M., García-Robledo, J. E., Plata, I., Urbano, M.-A., Posso‐Osorio, I., Ríos-Serna, L. J., Barrera, M. C., & Tobón, G. J. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2018.10.002 · Cited by 29
Decreased glucocorticoid receptor expression during critical illness
Vassiliou, A. G., Floros, G., Jahaj, E., Stamogiannos, G., Gennimata, S., Vassiliadi, D. A., Tsagarakis, S., Tzanela, M., Ilias, Ι., Orfanos, S. E., et al. (2019) · European Journal of Clinical Investigation · doi:10.1111/eci.13073 · Cited by 28
“GCR‐α (777 amino‐acid protein) is the predominant and functionally active receptor, whereas GCR‐β (742 amino‐acid protein) lacks most of the ligand‐binding domain, and hence is unable to bind natural and synthetic glucocorticoids, such as cortisol and dexamethasone, respectively.(12,13) Cortisol has to cross the cell…”
BackgroundClinical pharmacology of inflammatory bowel disease therapies
Sandborn, W. J., & Faubion, W. A. (2000) · Current Gastroenterology Reports · doi:10.1007/s11894-000-0005-0 · Cited by 28
“GRb appears to retard the transcriptional activity of GRa, possibly through dominant negative behavior at the level of GRE [16].”
BackgroundModulatory Effects of l‐Carnitine on Glucocorticoid Receptor Activity
Manoli, I., Martino, M. U. D., Kino, T., & Alesci, S. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1320.014 · Cited by 31
The pharmacogenetics of asthma: a candidate gene approach
Silverman, E. S., Liggett, S. B., Gelfand, E. W., Rosenwasser, L. J., Baron, R. M., Gabriel, S., Weiss, S. T., & Drazen, J. M. (2001) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500005 · Cited by 28
OPTIMIZING GLUCOCORTICOID THERAPY IN RHEUMATOID ARTHRITIS
António, P. D. S. J., & Bijlsma, J. W. J. (2000) · Rheumatic Disease Clinics of North America · doi:10.1016/s0889-857x(05)70173-3 · Cited by 31
Onda, K., Nagashima, M., Kawakubo, Y., Inoue, S., Hirano, T., & Oka, K. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.032 · Cited by 28
Geelhoed, J. J. M., van Duijn, C. M., van Osch-Gevers, L. M., Steegers, E. A. P., Albert Hofman, D., Helbing, W. A., & Jaddoe, V. W. V. (2010) · Early Human Development · doi:10.1016/j.earlhumdev.2010.11.006 · Cited by 27
“In vitro studies have shown that it can act as a dominant negative inhibitor of hGRα's transactivation properties [7].”
BackgroundMa, L., Fang, M., Liang, Y., Xiang, Y., Jia, Z., Sun, X., Wang, Y., & Qin, J.-X. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1705-5 · Cited by 28
Familial Glucocorticoid Resistance Caused by a Novel Frameshift Glucocorticoid Receptor Mutation
Trebble, P., Matthews, L. C., Blaikley, J., Wayte, A. W. O., Black, G. C. M., Wilton, A., & Ray, D. W. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-0705 · Cited by 29
Glucocorticoid receptor: implications for rheumatic diseases.
Kino, T., Charmandari, E., & Chrousos, G. P. (2011) · Clinical and Experimental Rheumatology · Cited by 32
Self-citationZhang, H. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i12.1775 · Cited by 27
Immunologic Basis of Chronic Allergic Diseases: Clinical Messages from the Laboratory Bench
Leung, D. Y. M. (1997) · Pediatric Research · doi:10.1203/00006450-199711000-00001 · Cited by 28
Flood, L., Löfberg, R., Stierna, P., & Wikström, A. (2001) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200108000-00004 · Cited by 27
“Using cotransfection systems with supraphysiological levels of GR , this receptor isoform has been shown to down-regulate the GR transaction properties in some laboratories (24,25) but not in others (26–28).”
MethodBiased regulation of glucocorticoid receptors signaling
Mao, L., Wei, W., & Chen, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115145 · Cited by 30
Huang, L., Xu, J., Kumta, S. M., & Zheng, M.-H. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00486-5 · Cited by 26
Molecular Mechanisms of Clucocorticoid Resistance/Hypersensitivity: Potential Clinical Implications
Chrousos, G. P., de Castro, M., Leung, D. Y. M., Webster, E., Kino, T., Bamberger, C. M., Elliot, S. J., Stratakis, C. A., & Karl, M. (1996) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm/154.2_pt_2.s39 · Cited by 26
Self-citationGlucocorticoid Receptor Mutations and Hypersensitivity to Endogenous and Exogenous Glucocorticoids
Santen, R. J., Jewell, C. M., Yue, W., Heitjan, D. F., Raff, H., Katen, K. S., & Cidlowski, J. A. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00352 · Cited by 25
Chin, J. S. R., Phan, T.-A. N., Albert, L. T., Keene, A. C., & Duboué, E. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-16257-5 · Cited by 30
Islam, M. N., Fujinaga, R., Yanai, A., Jahan, M. R., Takeshita, Y., Kokubu, K., & Shinoda, K. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.029 · Cited by 26
Bonifazi, M., Mencarelli, M., Fedele, V., Ceccarelli, I., Pecorelli, A., Grasso, G., Aloisi, A. M., & Muscettola, M. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03345751 · Cited by 26
The role of glucocorticoid receptor in prostate cancer progression: from bench to bedside
Hu, J., & Chen, Q. (2016) · International Urology and Nephrology · doi:10.1007/s11255-016-1476-8 · Cited by 28
WNT16 overexpression partly protects against glucocorticoid-induced bone loss
Ohlsson, C., Nilsson, K. H., Henning, P., Wu, J., Gustafsson, K. L., POUTANEN, M. H., Lerner, U. H., & Movérare‐Skrtic, S. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00292.2017 · Cited by 26
“However, when coexpressed with GR , GR functions as a dominant negative inhibitor and antagonizes the activity of GR on many GC-responsive target genes (4).”
BackgroundMeduri, G. U., Carratù, P., & Freire, A. X. (2003) · European Respiratory Journal · doi:10.1183/09031936.03.00420903 · Cited by 27
“or transrepression of genes that regulate mRNA stability and translation [ 34 ].”
BackgroundAdrenal Hyperandrogenism in Children
Ghizzoni, L. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.12.4431 · Cited by 25
“However, it has been recently postulated that hGRb might exert a specific dominant negative effect on transcriptional activation induced by hGRa (48, 49).”
BackgroundTliba, O., & Amrani, Y. (2008) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200705-060vs · Cited by 28
“Accordingly, the transfection studies investigating the dominant-negative activities of GRb were performed using exogenously expressed GRa and GRb in cells that do not express endogenous GRa such as COS-1 and COS-7 cells (85, 86).”
MethodGlucocorticoid receptor gene haplotype structure and steroid therapy outcome in IBD patients
Mwinyi, J., Wenger, C., Eloranta, J. J., & Kullak-Ublick, G. A. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i31.3888 · Cited by 29
Huang, J., Yang, Y.-F., Gao, X.-S., & Xu, Z.-H. (2023) · Journal of Orthopaedic Surgery and Research · doi:10.1186/s13018-023-03930-2 · Cited by 25
“Furthermore, a significant fraction of cortisol activity receptors translocated to the nucleus, and the increased expression of inactive receptors was observed in malnutrition [45, 46], which might reduce the combination and activity of cortisol, but the mechanism that nutrition how influences the effect of corticoste…”
BackgroundCould GILZ Be the Answer to Glucocorticoid Toxicity in Lupus?
Flynn, J. K., Dankers, W., & Morand, E. F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01684 · Cited by 26
“These include heterodimerization of GRβ with GRα to inactivate GRα, competition for binding at GREs and competition for binding to coactivators such as GRIP1 (53, 56, 57).”
BackgroundGlucocorticoid receptor alpha and beta isoforms are not mutated in bipolar affective disorder
Moutsatsou, P., Tsolakidou, A. F., Trikkas, G., Troungos, C., & Sekeris, C. E. (2000) · Molecular Psychiatry · doi:10.1038/sj.mp.4000646 · Cited by 28
Williams, S., & Ghosh, C. (2019) · Drug Discovery Today · doi:10.1016/j.drudis.2019.09.009 · Cited by 26
“Regulation of GRβ expression has been previously studied in various somatic cell lines, which have indicated GRβ function in negatively regulating the activity of GRα [45,46] and in reducing transactivation of the GRα isoform following stimulation by certain synthetic glucocorticoids [47].”
BackgroundGlucocorticoid receptor isoform expression does not predict steroid treatment response in IBD
Hausmann, M., Herfarth, H., Schölmerich, J., & Rogler, G. (2007) · Gut · doi:10.1136/gut.2006.108035 · Cited by 23
Colli, L. M., Amaral, F., Torres, N., & de Castro, M. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-980191 · Cited by 30
Corticosteroid Therapy in Asthma: Predictors of Responsiveness
Mjaanes, C. M., Whelan, G. J., & Szefler, S. J. (2006) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2005.10.005 · Cited by 25
“The b isoform also interferes at a cellular level with the actions of the GRa isoform [61,62,64–66].”
BackgroundINTRAOCULAR DEXAMETHASONE IMPLANT POSITION IN SITU AND OCULAR HYPERTENSION
Sudhalkar, A. A., Kodjikian, L., Chhablani, J. K., Bhojwani, D., & Vasavada, A. R. (2017) · Retina · doi:10.1097/iae.0000000000001883 · Cited by 22
Transcript variants of the porcine glucocorticoid receptor gene (NR3C1)
Reyer, H., Ponsuksili, S., Wimmers, K., & Muráni, E. (2013) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2013.04.038 · Cited by 29
Mohamed, N. A., Abdel-Rehim, A. S. M., Farres, M. N., & Muhammed, H. S. (2015) · Central European Journal of Immunology · doi:10.5114/ceji.2015.54594 · Cited by 25
“Exons from 2 to 8 function as the core sequences of the Nr3C1 gene [4].”
BackgroundSheng, Z., Yanai, A., Fujinaga, R., Kawano, J., Tanaka, M., Watanabe, Y., & Shinoda, K. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00056-7 · Cited by 25
Redox Regulation of the Glucocorticoid Receptor
Tanaka, H., Makino, Y., Okamoto, K., Iida, T., Yan, K., & Yoshikawa, N. (1999) · Antioxidants and Redox Signaling · doi:10.1089/ars.1999.1.4-403 · Cited by 25
Expression of human glucocorticoid receptor in lymphocytes of patients with autoimmune hepatitis
RAI, T., Ohira, H., Tojo, J., Abe, K., Yokokawa, J., Takiguchi, J., SHISHIDO, S., & Sato, Y. (2004) · Hepatology Research · doi:10.1016/j.hepres.2004.03.004 · Cited by 22
Yan, Y., Dong, J., Wu, L., Shao, S., Zhang, J., Zhang, L., Wang, W., He, Y. L., & Liu, Y.-Q. (2013) · Journal of Epidemiology · doi:10.2188/jea.je20130035 · Cited by 22
“The study inclusion criteria were as follows: (1) no history of somatic or psychiatric abnormalities, as confirmed by patient medical records, (2) age 20 through 60 years, and (3) no history of medication use during the previous 2 weeks.”
BackgroundMarchi, D., & van Eeden, F. J. M. (2021) · Cells · doi:10.3390/cells10123441 · Cited by 27
Liu, J., Wan, Z., Song, Q., Li, Z., He, Y., Tang, Y., Xie, W., Xie, Y., & Zhang, J. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0084 · Cited by 24
Brivio, P., Buoso, E., Masi, M., Gallo, M. T., Gruca, P., Łasoń, M., Litwa, E., Papp, M., Fumagalli, F., Racchi, M., et al. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100372 · Cited by 20
“, 1996) and that it mainly acts as a dominant-negative regulator of Grα, by affecting the transcriptional activity mediated by the Grα isoform (Bamberger et al., 1995; Kino et al., 2009b; Oakley et al., 1996).”
Haridas, V., Xu, Z., Kitchen, D. B., Jiang, A., Michels, P. C., & Gutterman, J. U. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028037 · Cited by 27
“Cold competition binding assays were done as per Bamberger’s protocol [9].”
MethodMechanism of steroid action in renal epithelial cells
de Haij, S., Daha, M. R., & van Kooten, C. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00553.x · Cited by 23
“We also excluded that lack of inhibition by dexamethasone was caused by overexpression of the glucocorticoid receptor b isoform that could competitively inhibit the functional glucocorticoid receptor a as was suggested in other studies [80, 81].”
ResultTakahashi, E., Onda, K., Hirano, T., Oka, K., Maruoka, N., Tsuyuguchi, M., Matsumura, Y., Niitsuma, T., & Hayashi, T. (2002) · International Immunopharmacology · doi:10.1016/s1567-5769(02)00083-8 · Cited by 20
The Human Glucocorticoid Receptor Beta: From Molecular Mechanisms to Clinical Implications
Nicolaides, N. C. (2022) · Endocrinology · doi:10.1210/endocr/bqac150 · Cited by 23
Potential Role of Glucocorticoid Signaling in the Formation of Pancreatic Islets in the Human Fetus
Phan-Hug, F., Guimiot, F., Lelièvre, V., Delezoide, A., Czernichow, P., Bréant, B., & Blondeau, B. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e318180a38f · Cited by 22
Nicolaides, N. C., & Charmandari, E. (2019) · Experientia supplementum · doi:10.1007/978-3-030-25905-1_6 · Cited by 25
Jacques, É., Semlali, A., Boulet, L., & Chakir, J. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00360.2009 · Cited by 25
Xiu, L., ZHANG, F.-S., Zhang, J., & Wang, J. (2009) · The Journal of Rheumatology · doi:10.3899/jrheum.090191 · Cited by 20
Siriani, D., Mitsiou, D. J., & Alexis, Μ. N. (2003) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(03)00027-x · Cited by 20
Syndromes of glucocorticoid and mineralocorticoid resistance
Zennaro, M. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390127 · Cited by 19
A Rational Approach to the Management of Severe Refractory Asthma
Bel, E. H., & Brinke, A. T. (2005) · Treatments in Respiratory Medicine · doi:10.2165/00151829-200504060-00002 · Cited by 21
Ogias, D., Sá, E. R. D. A., Kasai, A., Moisan, M., Álvares, E. P., & Gama, P. (2009) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00245.2009 · Cited by 19
Chatzopoulou, A., Schoonheim, P. J., Torraca, V., Meijer, A. H., Spaink, H. P., & Schaaf, M. J. M. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.02.036 · Cited by 22
“Second, hGRb’s expression levels are significantly lower compared to those of hGRa (Bamberger et al., 1995; de Castro et al., 1996; Oakley et al., 1996, 1997; Pujols et al., 2002; Strickland et al., 2001).”
InfluentialExpression and function of MIP‐2 are reduced by dexamethasone treatment in vivo
Schramm, R., Liu, Q., & Thorlacius, H. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703543 · Cited by 19
Andersson, O., Cassel, T. N., Grönneberg, R., Brönnegård, M., Stierna, P., & Nord, M. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70230-7 · Cited by 20
Quagliarini, F., Makris, K., Friano, M. E., & Uhlenhaut, N. H. (2023) · European Journal of Endocrinology · doi:10.1093/ejendo/lvad048 · Cited by 22
Search for a functional glucocorticoid receptor in the mammalian lens
Gupta, V., & Wagner, B. J. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.04.003 · Cited by 20
Novel Hyperactive Glucocorticoid Receptor Isoform Identified Within a Human Population
Tung, K. L., Baker, A. C., Amini, A., Green, T. L., Chew, V. W., Lim, D., Nguyen, S., Yee, K. S., Cho, K., & Greenhalgh, D. G. (2011) · Shock · doi:10.1097/shk.0b013e318228eca7 · Cited by 19
“In addition to acting as a competitive inhibitor for the GRE target sites, other studies suggest the inhibitory effect of hGR" occurs because it forms a heterodimer with hGR! to block activity (36, 37).”
Background
Metadata
- Authors
- Bamberger, C. M., Bamberger, A. M., de Castro, M., & Chrousos, G. P.
- Affiliations
- National Institutes of Health (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1995-06-01
- Volume
- 95
- Issue
- 6
- Pages
- 2435-2441
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC295915
- OpenAlex
- W1974791065
- Cited by
- 642
- References
- 41
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 9 · 2023: 13 · 2022: 6 · 2021: 13 · 2020: 7 · 2019: 25 · 2018: 21 · 2017: 18 · 2016: 23 · 2015: 21 · 2014: 15 · 2013: 16 · 2012: 18
- FWCI
- 15.18
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Deutsche Forschungsgemeinschaft
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoid receptor beta, glucocorticoid receptor alpha, alternative splicing, receptor isoforms, glucocorticoid response element, transcriptional repression, dexamethasone binding, glucocorticoid sensitivity
- MeSH terms
- Animals, Base Sequence, Cells, Cultured, Chlorocebus aethiops, Dexamethasone, DNA-Binding Proteins, Glucocorticoids, Humans, Molecular Sequence Data, Receptors, Glucocorticoid, Recombinant Proteins, Regulatory Sequences, Nucleic Acid, RNA, Messenger, Transcription, Genetic, Gene Expression, Alternative Splicing, DNA Primers, In Vitro Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.